605 related articles for article (PubMed ID: 26817581)
21. Changes in CD4+ and CD8+ T cell subsets in response to highly active antiretroviral therapy in HIV type 1-infected patients with prior protease inhibitor experience.
Gray CM; Schapiro JM; Winters MA; Merigan TC
AIDS Res Hum Retroviruses; 1998 May; 14(7):561-9. PubMed ID: 9591710
[TBL] [Abstract][Full Text] [Related]
22. Cd38 expression on Cd8+ T cells in Human immunodeficiency virus 1-positive adults treated with HAART.
Beran O; Holub M; Spála J; Kalanin J; Stanková M
Acta Virol; 2003; 47(2):121-4. PubMed ID: 14524479
[TBL] [Abstract][Full Text] [Related]
23. A pilot study to assess inflammatory biomarker changes when raltegravir is added to a virologically suppressive HAART regimen in HIV-1-infected patients with limited immunological responses.
Lichtenstein KA; Armon C; Nagabhushanam V; Efaw BJ; Frazer-Abel A; Hiserote ME; Alam R
Antivir Ther; 2012; 17(7):1301-9. PubMed ID: 22948290
[TBL] [Abstract][Full Text] [Related]
24. Rapid CD4 decline prior to antiretroviral therapy predicts subsequent failure to reconstitute despite HIV viral suppression.
Darraj M; Shafer LA; Chan S; Kasper K; Keynan Y
J Infect Public Health; 2018; 11(2):265-269. PubMed ID: 28826735
[TBL] [Abstract][Full Text] [Related]
25. Impaired Th17 polarization of phenotypically naive CD4(+) T-cells during chronic HIV-1 infection and potential restoration with early ART.
DaFonseca S; Niessl J; Pouvreau S; Wacleche VS; Gosselin A; Cleret-Buhot A; Bernard N; Tremblay C; Jenabian MA; Routy JP; Ancuta P
Retrovirology; 2015 Apr; 12():38. PubMed ID: 25924895
[TBL] [Abstract][Full Text] [Related]
26. Lower CD4+ T lymphocyte nadirs may indicate limited immune reconstitution in HIV-1 infected individuals on potent antiretroviral therapy: analysis of immunophenotypic marker results of AACTG 5067.
D'Amico R; Yang Y; Mildvan D; Evans SR; Schnizlein-Bick CT; Hafner R; Webb N; Basar M; Zackin R; Jacobson MA
J Clin Immunol; 2005 Mar; 25(2):106-15. PubMed ID: 15821887
[TBL] [Abstract][Full Text] [Related]
27. Association between discordant immunological response to highly active anti-retroviral therapy, regulatory T cell percentage, immune cell activation and very low-level viraemia in HIV-infected patients.
Saison J; Ferry T; Demaret J; Maucort Boulch D; Venet F; Perpoint T; Ader F; Icard V; Chidiac C; Monneret G;
Clin Exp Immunol; 2014 Jun; 176(3):401-9. PubMed ID: 24460818
[TBL] [Abstract][Full Text] [Related]
28. CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load.
Sousa AE; Carneiro J; Meier-Schellersheim M; Grossman Z; Victorino RM
J Immunol; 2002 Sep; 169(6):3400-6. PubMed ID: 12218162
[TBL] [Abstract][Full Text] [Related]
29. Presence of human immunodeficiency virus-1-specific CD4 and CD8 cellular immune responses in children with full or partial virus suppression.
Papasavvas E; Sandberg JK; Rutstein R; Moore EC; Mackiewicz A; Thiel B; Pistilli M; June RR; Jordan KA; Gross R; Maino VC; Nixon DF; Montaner LJ
J Infect Dis; 2003 Sep; 188(6):873-82. PubMed ID: 12964119
[TBL] [Abstract][Full Text] [Related]
30. Positive association between beta-chemokine-producing T cells and HIV type 1 viral load in HIV-infected subjects in Abidjan, Côte d'Ivoire.
Jennes W; Sawadogo S; Koblavi-Dème S; Vuylsteke B; Maurice C; Roels TH; Chorba T; Nkengasong JN; Kestens L
AIDS Res Hum Retroviruses; 2002 Feb; 18(3):171-7. PubMed ID: 11839151
[TBL] [Abstract][Full Text] [Related]
31. Imbalanced production of cytokines by T cells associates with the activation/exhaustion status of memory T cells in chronic HIV type 1 infection.
Nakayama K; Nakamura H; Koga M; Koibuchi T; Fujii T; Miura T; Iwamoto A; Kawana-Tachikawa A
AIDS Res Hum Retroviruses; 2012 Jul; 28(7):702-14. PubMed ID: 21902582
[TBL] [Abstract][Full Text] [Related]
32. Proportions of circulating T cells with a regulatory cell phenotype increase with HIV-associated immune activation and remain high on antiretroviral therapy.
Lim A; Tan D; Price P; Kamarulzaman A; Tan HY; James I; French MA
AIDS; 2007 Jul; 21(12):1525-34. PubMed ID: 17630546
[TBL] [Abstract][Full Text] [Related]
33. Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers.
Messele T; Brouwer M; Girma M; Fontanet AL; Miedema F; Hamann D; Rinke de Wit TF
Clin Immunol; 2001 Feb; 98(2):212-9. PubMed ID: 11161977
[TBL] [Abstract][Full Text] [Related]
34. Human Immunodeficiency Virus Type-1 Elite Controllers Maintain Low Co-Expression of Inhibitory Receptors on CD4+ T Cells.
Noyan K; Nguyen S; Betts MR; Sönnerborg A; Buggert M
Front Immunol; 2018; 9():19. PubMed ID: 29403500
[TBL] [Abstract][Full Text] [Related]
35. The effect of a year of highly active antiretroviral therapy on immune reconstruction and cytokines in HIV/AIDS patients.
Yao Y; Luo Y; He Y; Zheng Y; Zhang Q; Zhou H; Zeng S; Chen Z; He B; He M
AIDS Res Hum Retroviruses; 2013 Apr; 29(4):691-7. PubMed ID: 23151174
[TBL] [Abstract][Full Text] [Related]
36. Central memory CD4 T cells are associated with incomplete restoration of the CD4 T cell pool after treatment-induced long-term undetectable HIV viraemia.
Rallón N; Sempere-Ortells JM; Soriano V; Benito JM
J Antimicrob Chemother; 2013 Nov; 68(11):2616-25. PubMed ID: 23833186
[TBL] [Abstract][Full Text] [Related]
37. Identification of PD-1 as a unique marker for failing immune reconstitution in HIV-1-infected patients on treatment.
Grabmeier-Pfistershammer K; Steinberger P; Rieger A; Leitner J; Kohrgruber N
J Acquir Immune Defic Syndr; 2011 Feb; 56(2):118-24. PubMed ID: 20980914
[TBL] [Abstract][Full Text] [Related]
38. Role of in vitro stimulation with lipopolysaccharide on T-cell activation in HIV-infected antiretroviral-treated patients.
Tincati C; Bellistrì GM; Ancona G; Merlini E; d'Arminio Monforte A; Marchetti G
Clin Dev Immunol; 2012; 2012():935425. PubMed ID: 22400042
[TBL] [Abstract][Full Text] [Related]
39. Assessment of chloroquine as a modulator of immune activation to improve CD4 recovery in immune nonresponding HIV-infected patients receiving antiretroviral therapy.
Routy JP; Angel JB; Patel M; Kanagaratham C; Radzioch D; Kema I; Gilmore N; Ancuta P; Singer J; Jenabian MA
HIV Med; 2015 Jan; 16(1):48-56. PubMed ID: 24889179
[TBL] [Abstract][Full Text] [Related]
40. A Low Frequency of IL-17-Producing CD8
Perdomo-Celis F; Feria MG; Taborda NA; Rugeles MT
Front Immunol; 2018; 9():2502. PubMed ID: 30420859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
